10 Apr 2019

Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

NaTHNaC receives reassurance that contingencies for continuous yellow fever vaccine supply to the UK are robust and sustainable in the event of a ‘no deal’ EU Exit Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

On behalf of Yellow Fever Vaccination Centres (YFVC) in England, Wales and Northern Ireland, NaTHNaC has been working closely with Sanofi Pasteur who manufacture, pack and supply yellow fever vaccine in France for the UK market. Sanofi Pasteur advises that their contingency plan for a ‘no deal’ EU Exit includes increasing yellow fever vaccine stock levels and securing alternative and robust supply lines into the UK.

Local stockpiling is unnecessary and YFVC should continue to order YF vaccine as usual.

Further updates will be provided when available.

Resources

Malaria-free certification: Algeria and Argentina

The World Health Organization has granted Algeria and Argentina certification of malaria-free status Read more

Ebola Virus Disease (EVD) in Democratic Republic of Congo

A steady increase in cases is reported in the areas affected by the ongoing epidemic Read more

Antibiotic resistance and international travel

Antimicrobial resistant infections are rising in all parts of the world Read more

Public Health England post-exposure rabies treatment guidance published

Updated guidelines on rabies post-exposure treatment Read more

Hepatitis A vaccine recommendations for Turkey updated

Hepatitis A vaccine is recommended for most travellers to Turkey Read more
Back to Top

VIEW FULL INDEX